Save for a few minutes early on in the session, the Switzerland market languished in negative territory on Thursday as investors remained reluctant to make significant moves, digesting the central bank’s rate decision, and closely following geopolitical news.
The benchmark SMI ended with a loss of 49.41 points or 0.36% at 13,765.83 after scaling a high of 13,836.55 and a low of 13,743.43 intraday.
Drugmakers Roche (down 2.68%) and Novartis (down 2.45%), were the major losers in the benchmark index. Partners Group drifted down nearly 2%, while Sandoz Group ended 1.6% down.
Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial – No Payment Required
Swiss Market Ends Modestly Lower
2026-06-18 18:07:47
